myelofibrosis

February 1, 2018
clinical trial in myelofibrosis
Published by mpncancer at February 1, 2018
Categories

Imago BioSciences gets FDA Approval of IND Application for Treatment of Myelofibrosis, IMG-7289 in Clinical Trials

Imago BioSciences, a clinical-stage pharmaceutical company developing novel therapies for hematological and inflammatory diseases, announced that the U.S. Food and Drug Administration (FDA) has accepted their […]
Do you like it?0
Read more
June 29, 2017
Pegasys Jakafi combo for MPNs
Published by mpncancer at June 29, 2017
Categories

Minimal Residual Disease or Cure in MPNs? Rationales and perspectives on Combo Therapy with Interferon-alpha2 and Ruxolitinib

This abstract is provided by Mads Emil Bjorn & Hans Carl Hasselbalch – Department of Hematology, Region Zealand, Roskilde, Denmark Abstract Introduction: The therapeutic landscape of […]
Do you like it?0
Read more
June 5, 2017
Immunofluorescence of single human cell stained grown in tissue culture, stained with multiple antibodies and visualized via confocal microscopy
Published by David Wallace at June 5, 2017
Categories

A New Therapeutic Target for Myelofibrosis is cause for Gli

Abstract Myeloproliferative neoplasm cells recruit Gli1 positive mesenchymal stromal cells to transdifferentiate into fibrosis-causing myofibroblasts, a process that can be inhibited by a Gli inhibitor. Bone […]
Do you like it?0
Read more
August 30, 2016
Understanding the JAK2 mutation
Published by mpncancer at August 30, 2016
Categories

Understanding the JAK2 Mutation

THE STORY OF JAK2 Four teams race to find the mysterious cause of a group of blood cancers. Click the link below for the complete article…
Do you like it?0
Read more
Do NOT follow this link or you will be banned from the site!
Malcare WordPress Security